Author

Vanessa Bernstein

Observed names: Bernstein Vanessa, Bernstein, Vanessa, V Bernstein, V. Bernstein

Observed institutions: BC Cancer Agency, Mount Sinai Hospital, Mount Sinai Hospital, University Health Network, University of British Columbia, University of Pittsburgh, University of Toronto, Vanderbilt University, Queen's University, Lunenfeld-Tanenbaum Research Institute, Princess Margaret Cancer Centre, Vancouver General Hospital, Dana-Farber Cancer Institute, Canadian Cancer Trials Group, Columbia University

ORCID: 0000-0001-6216-8376

Observed ORCID: 0000-0001-6216-8376

OpenAlex ID: A5016745127

Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32

2015 · P. J. Goodwin, W. R. Parulekar, et al. · JNCI Journal of the National Cancer Institute · 130

PDF

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

2019 · T. Bachelot, E. Ciruelos, et al. · Annals of Oncology · 114

PDF

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design

2017 · Jennifer A. Ligibel, William T. Barry, et al. · npj Breast Cancer · 103

PDF

A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.

2017 · V. Bernstein, S. L. Ellard, et al. · Breast Cancer Research and Treatment · 99

Time to Stop Progesterone Receptor Testing in Breast Cancer Management

2004 · Ivo A. Olivotto, Pauline T. Truong, et al. · Journal of Clinical Oncology · 86

Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?

2014 · Wilson Sheridan, Tyldesley Scott, et al. · Breast Cancer Research and Treatment · 82

Is Mastectomy Superior to Breast-Conserving Treatment for Young Women?

2007 · Geneviève Coulombe, Scott Tyldesley, et al. · International Journal of Radiation Oncology*Biology*Physics · 75

The Value of FDG Positron Emission Tomography in the Management of Patients with Breast Cancer

2005 · Lorna Weir, Daniel Worsley, et al. · The Breast Journal · 75

Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer–specific survival in elderly women with breast cancer

2006 · Pauline T. Truong, Vanessa Bernstein, et al. · The American Journal of Surgery · 71

2002 · Pauline T Truong, Vanessa Bernstein, et al. · International Journal of Radiation Oncology*Biology*Physics · 57

Should Women Younger Than 40 Years of Age With Invasive Breast Cancer Have a Mastectomy?: 15-Year Outcomes in a Population-Based Cohort

2014 · Jeffrey Q. Cao, Pauline T. Truong, et al. · International Journal of Radiation Oncology*Biology*Physics · 40

The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle intervention

2021 · Linda M. Delahanty, Thomas A. Wadden, et al. · Obesity · 28

Adjuvant Radiation Therapy After Breast-Conserving Surgery in Elderly Women with Early-Stage Breast Cancer: Controversy or Consensus?

2004 · Pauline T. Truong, Elaine Wong, et al. · Clinical Breast Cancer · 21

Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32

2017 · From the CCTG, Alliance, SWOG, ECOG, NSABP Cooperative Groups, Ana Elisa Lohmann, et al. · Breast Cancer Research and Treatment · 15

Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer

2025 · Jennifer A. Ligibel, Karla V. Ballman, et al. · JAMA Oncology · 13

The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401).

2018 · Jennifer A. Ligibel, William Thomas Barry, et al. · Journal of Clinical Oncology · 13

Effect of a telephone-based weight loss intervention (WLI) on weight at 12-months in women with early breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial.

2023 · Jennifer A. Ligibel, Karla V. Ballman, et al. · Journal of Clinical Oncology · 11

Effect of metformin versus placebo on weight and metabolic factors in initial patients enrolled onto NCIC CTG MA.32, a multicenter adjuvant randomized controlled trial in early-stage breast cancer (BC).

2013 · Pamela Jean Goodwin, Wendy Parulekar, et al. · Journal of Clinical Oncology · 6

The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

2025 · Tess Aalto, Maria Abacan, et al. · Cancer Cell · 5

Delayed immune-related adverse events in patients with advanced melanoma treated with immune checkpoint inhibitors.

2024 · Arkhjamil Angeles, Eric Sonke, et al. · Journal of Clinical Oncology · 5

Abstract CT131: A randomized (RCT) phase II study of oncolytic reovirus (pelareorep ) plus standard weekly paclitaxel (P) as therapy for metastatic breast cancer (mBC)

2017 · Vanessa Bernstein, Susan Ellard, et al. · Cancer Research · 4

2001 · P Truong, V Bernstein, et al. · International Journal of Radiation Oncology*Biology*Physics · 2

PDF

Low concentration galactose determination in plasma adapted to the cobas-bio

1990 · Morris R. Pudek, Azim Jamani, et al. · Clinical Biochemistry · 2

Effect of a weight loss intervention (WLI) on quality of life (QOL) and symptoms in women with breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial.

2026 · Jennifer A. Ligibel, Dawn L. Hershman, et al. · Journal of Clinical Oncology · 1

In Reply:

2005 · Ivo A. Olivotto, Pauline T. Truong, et al. · Journal of Clinical Oncology · 1

PDF

Works count: 38

Citation count: 1,059

H-index: 14

I10-index: 17